Acute Myeloid Leukemia Market Report 2026
Download Free Sample Buy Now
Acute Myeloid Leukemia Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Acute Myeloid Leukemia Market Report 2026

Global Outlook – By Treatment Type (Chemotherapy, Stem Cell Transplant, Targeted Therapy), By Treatment Phase (Induction Therapy, Consolidation Therapy, Maintenance Therapy, Relapsed Or Refractory Therapy), By End-User (Hospitals, Specialty Oncology Centers, Transplant Centers, Research and Academic Institutes) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Acute Myeloid Leukemia Market Overview

• Acute Myeloid Leukemia market size has reached to $3.73 billion in 2025

• Expected to grow to $5.25 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%

• Growth Driver: Rising Adoption Of Personalized Medicine To Drive Market Growth

• Market Trend: Pharmaceutical Companies Enhancing Acute Myeloid Leukemia Treatment Armamentarium With Quizartinib Approval

• North America was the largest region in 2025.

What Is Covered Under Acute Myeloid Leukemia Market?

Acute myeloid leukemia (AML) is a type of blood cancer that occurs due to abnormal white blood cell in bone marrow. Myeloblasts, also known as leukemic blasts, or excessive production of immature white blood cells, are the hallmark of AML. The bone marrow is crowded with these cells, which stops it from producing healthy blood cells.

The main acute myeloid leukemia treatment types include chemotherapy, radiation therapy, stem cell transplant, and targeted therapy. Chemotherapy is a drug treatment that uses powerful chemicals to kill fast-growing cells in the body. The different acute myeloid leukemia chemotherapies include cytarabine, anthracycline drugs, alkylating agents, anti-metabolites, tyrosine kinase inhibitors, and hormonal therapy. They are of various regimens such as DC regimen, AVD regimen, and VCD regimen. Acute myeloid leukemia is treated by different end-users such as hospitals, retail drug stores, ambulatory care centers, and clinics.

Acute Myeloid Leukemia Market Global Report 2026 Market Report bar graph

What Is The Acute Myeloid Leukemia Market Size and Share 2026?

The acute myeloid leukemia market size has grown strongly in recent years. It will grow from $3.73 billion in 2025 to $3.97 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rising prevalence of aml, growing hospital infrastructure, increasing awareness about leukemia treatments, adoption of conventional chemotherapy protocols, development of supportive care measures.

What Is The Acute Myeloid Leukemia Market Growth Forecast?

The acute myeloid leukemia market size is expected to see strong growth in the next few years. It will grow to $5.25 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to advancement in targeted therapy drugs, increasing stem cell transplant procedures, development of novel tyrosine kinase inhibitors, expansion of ambulatory care centers, integration of personalized medicine approaches in treatment. Major trends in the forecast period include increasing adoption of targeted aml therapies, rising use of stem cell transplantation procedures, growing demand for personalized chemotherapy regimens, expansion of tyrosine kinase inhibitors and monoclonal antibodies, enhanced focus on early diagnosis and aml monitoring.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Acute Myeloid Leukemia Market Segmentation

1) By Treatment Type: Chemotherapy, Stem Cell Transplant, Targeted Therapy

2) By Treatment Phase: Induction Therapy, Consolidation Therapy, Maintenance Therapy, Relapsed Or Refractory Therapy

3) By End-User: Hospitals, Specialty Oncology Centers, Transplant Centers, Research and Academic Institutes

Subsegments:

1) By Chemotherapy: Cytarabine-Based Therapy, Anthracycline-Based Therapy, Hypomethylating Agents, Low-Intensity Chemotherapy, Combination Chemotherapy Regimens

2) By Stem Cell Transplant: Allogeneic Stem Cell Transplant, Autologous Stem Cell Transplant, Conditioning Regimens, Post-Transplant Maintenance Therapy

3) By Targeted Therapy: FLT3 Inhibitors, IDH1 Inhibitors, IDH2 Inhibitors, BCL-2 Inhibitors, Hedgehog Pathway Inhibitors, Monoclonal Antibodies, Other Targeted Agents

What Is The Driver Of The Acute Myeloid Leukemia Market?

The increasing adoption of personalized medicine is expected to propel the growth of the acute myeloid leukemia market going forward. Personalized medicine is an innovative approach to medical treatment and healthcare that considers individual differences in patients' genes, environments, and lifestyles. In acute myeloid leukemia (AML), personalized medicine is employed through molecular profiling to identify specific genetic mutations and biomarkers unique to individual patients. This information guides the selection of targeted therapies and tailored treatment plans, optimizing the effectiveness of interventions while minimizing adverse effects for a more personalized and precise approach to AML management. For instance, in February 2024, according to the Personalised Medicine Coalition, a US-based hospital and health care organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the increasing adoption of personalized medicine is driving the growth of the acute myeloid leukemia industry.

Key Players In The Global Acute Myeloid Leukemia Market

Major companies operating in the acute myeloid leukemia market are Pfizer Inc., AbbVie Inc., Novartis AG, Bristol Myers Squibb Company, F. Hoffmann-La Roche AG, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Servier Pharmaceuticals, Amgen Inc., Otsuka Holdings Co. Ltd., Agios Pharmaceuticals Inc., Syndax Pharmaceuticals Inc., MEI Pharma Inc., SELLAS Life Sciences Group, Genmab AS, Aptose Biosciences Inc., Daiichi Sankyo Company Limited, BeiGene Ltd., Jazz Pharmaceuticals plc, Ipsen S.A.

Global Acute Myeloid Leukemia Market Trends and Insights

Major companies operating in the acute myeloid leukemia market are focused on developing advanced drug solutions, such as maintenance monotherapy, to expand their product portfolios to improve patient outcomes and address unmet medical needs. Maintenance monotherapy refers to a medical treatment approach where a single therapeutic agent is administered to a patient as an ongoing, long-term therapy to prevent the recurrence or progression of a medical condition. For instance, in July 2023, Daiichi Sankyo Company Limited, a Japan-based pharmaceutical company, received United States Food and Drug Administration (USFDA) approval for quizartinib (Vanflyta) in combination with standard cytarabine and anthracycline induction, followed by cytarabine consolidation, and as maintenance monotherapy for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults with FLT3 internal tandem duplication (ITD)-positive status, as determined by an FDA-approved test. The LeukoStrat CDx FLT3 Mutation Assay has also been approved as a companion diagnostic for Vanflyta. The approval is based on positive results from the QuANTUM-First trial, showing a statistically significant improvement in overall survival for patients receiving quizartinib compared to a placebo. Quizartinib's recommended dosage varies during induction, consolidation, and maintenance phases. The drug is not indicated as maintenance monotherapy following allogeneic hematopoietic stem cell transplantation.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Acute Myeloid Leukemia Market?

In March 2023, QIAGEN, a Netherlands-based biotechnology company, partnered with Servier Laboratories, for an undisclosed amount. This partnership aims to develop a companion diagnostic test for TIBSOVO, an isocitrate dehydrogenase-1 (IDH1) inhibitor intended for treating acute myeloid leukemia (AML). Under this Master Collaboration Agreement, QIAGEN will create and validate a real-time in vitro PCR test designed to detect IDH1 gene mutations in AML patients using blood and bone marrow samples. This collaboration enhances the global accessibility of TIBSOVO for AML patients with IDH1 mutations and reinforces QIAGEN's role in developing companion diagnostics for emerging biomarkers in onco-hematology, furthering precision medicine initiatives. Servier Laboratories, a France-based pharmaceutical company.

Regional Outlook

North America was the largest region in the acute myeloid leukemia market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acute Myeloid Leukemia Market?

The acute myeloid leukemia market includes revenue earned by drugs such as DC regimen, AVD Regimen, VCD regimen, cytarabine, vidaza, dacogen, midostaurin, quizartinib, vosaroxin that are used for the treatment of acute myeloid leukemia. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Acute Myeloid Leukemia Market Report 2026?

The acute myeloid leukemia market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the acute myeloid leukemia industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Acute Myeloid Leukemia Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $3.97 billion
Revenue Forecast In 2035 $5.25 billion
Growth Rate CAGR of 6.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment Type, Treatment Phase, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., AbbVie Inc., Novartis AG, Bristol Myers Squibb Company, F. Hoffmann-La Roche AG, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Servier Pharmaceuticals, Amgen Inc., Otsuka Holdings Co. Ltd., Agios Pharmaceuticals Inc., Syndax Pharmaceuticals Inc., MEI Pharma Inc., SELLAS Life Sciences Group, Genmab AS, Aptose Biosciences Inc., Daiichi Sankyo Company Limited, BeiGene Ltd., Jazz Pharmaceuticals plc, Ipsen S.A.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Acute Myeloid Leukemia Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Acute Myeloid Leukemia Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Acute Myeloid Leukemia Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Acute Myeloid Leukemia Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Targeted Aml Therapies

4.2.2 Rising Use Of Stem Cell Transplantation Procedures

4.2.3 Growing Demand For Personalized Chemotherapy Regimens

4.2.4 Expansion Of Tyrosine Kinase Inhibitors And Monoclonal Antibodies

4.2.5 Enhanced Focus On Early Diagnosis And Aml Monitoring

5. Acute Myeloid Leukemia Market Analysis Of End Use Industries

5.1 Hospital

5.2 Retails Drug Stores

5.3 Ambulatory Care Centers

5.4 Clinics

5.5 Oncology Research Centers

6. Acute Myeloid Leukemia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Acute Myeloid Leukemia Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Acute Myeloid Leukemia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Acute Myeloid Leukemia Market Size, Comparisons And Growth Rate Analysis

7.3. Global Acute Myeloid Leukemia Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Acute Myeloid Leukemia Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Acute Myeloid Leukemia Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Acute Myeloid Leukemia Market Segmentation

9.1. Global Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chemotherapy, Stem Cell Transplant, Targeted Therapy

9.2. Global Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Induction Therapy, Consolidation Therapy, Maintenance Therapy, Relapsed Or Refractory Therapy

9.3. Global Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Oncology Centers, Transplant Centers, Research and Academic Institutes

9.4. Global Acute Myeloid Leukemia Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cytarabine-Based Therapy, Anthracycline-Based Therapy, Hypomethylating Agents, Low-Intensity Chemotherapy, Combination Chemotherapy Regimens

9.5. Global Acute Myeloid Leukemia Market, Sub-Segmentation Of Stem Cell Transplant, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Allogeneic Stem Cell Transplant, Autologous Stem Cell Transplant, Conditioning Regimens, Post-Transplant Maintenance Therapy

9.6. Global Acute Myeloid Leukemia Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

FLT3 Inhibitors, IDH1 Inhibitors, IDH2 Inhibitors, BCL-2 Inhibitors, Hedgehog Pathway Inhibitors, Monoclonal Antibodies

10. Acute Myeloid Leukemia Market Regional And Country Analysis

10.1. Global Acute Myeloid Leukemia Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Acute Myeloid Leukemia Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Acute Myeloid Leukemia Market

11.1. Asia-Pacific Acute Myeloid Leukemia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Acute Myeloid Leukemia Market

12.1. China Acute Myeloid Leukemia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Acute Myeloid Leukemia Market

13.1. India Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Acute Myeloid Leukemia Market

14.1. Japan Acute Myeloid Leukemia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Acute Myeloid Leukemia Market

15.1. Australia Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Acute Myeloid Leukemia Market

16.1. Indonesia Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Acute Myeloid Leukemia Market

17.1. South Korea Acute Myeloid Leukemia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Acute Myeloid Leukemia Market

18.1. Taiwan Acute Myeloid Leukemia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Acute Myeloid Leukemia Market

19.1. South East Asia Acute Myeloid Leukemia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Acute Myeloid Leukemia Market

20.1. Western Europe Acute Myeloid Leukemia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Acute Myeloid Leukemia Market

21.1. UK Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Acute Myeloid Leukemia Market

22.1. Germany Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Acute Myeloid Leukemia Market

23.1. France Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Acute Myeloid Leukemia Market

24.1. Italy Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Acute Myeloid Leukemia Market

25.1. Spain Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Acute Myeloid Leukemia Market

26.1. Eastern Europe Acute Myeloid Leukemia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Acute Myeloid Leukemia Market

27.1. Russia Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Acute Myeloid Leukemia Market

28.1. North America Acute Myeloid Leukemia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Acute Myeloid Leukemia Market

29.1. USA Acute Myeloid Leukemia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Acute Myeloid Leukemia Market

30.1. Canada Acute Myeloid Leukemia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Acute Myeloid Leukemia Market

31.1. South America Acute Myeloid Leukemia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Acute Myeloid Leukemia Market

32.1. Brazil Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Acute Myeloid Leukemia Market

33.1. Middle East Acute Myeloid Leukemia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Acute Myeloid Leukemia Market

34.1. Africa Acute Myeloid Leukemia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Segmentation By Treatment Phase, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Acute Myeloid Leukemia Market Regulatory and Investment Landscape

36. Acute Myeloid Leukemia Market Competitive Landscape And Company Profiles

36.1. Acute Myeloid Leukemia Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Acute Myeloid Leukemia Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Acute Myeloid Leukemia Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.5. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

37. Acute Myeloid Leukemia Market Other Major And Innovative Companies

Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Servier Pharmaceuticals, Amgen Inc., Otsuka Holdings Co. Ltd., Agios Pharmaceuticals Inc., Syndax Pharmaceuticals Inc., MEI Pharma Inc., SELLAS Life Sciences Group, Genmab AS, Aptose Biosciences Inc., Daiichi Sankyo Company Limited, BeiGene Ltd., Jazz Pharmaceuticals plc, Ipsen S.A.

38. Global Acute Myeloid Leukemia Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Acute Myeloid Leukemia Market

40. Acute Myeloid Leukemia Market High Potential Countries, Segments and Strategies

40.1 Acute Myeloid Leukemia Market In 2030 - Countries Offering Most New Opportunities

40.2 Acute Myeloid Leukemia Market In 2030 - Segments Offering Most New Opportunities

40.3 Acute Myeloid Leukemia Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Acute Myeloid Leukemia Market, Overview Of Key Products - Product Examples
  • Table 2: Global Acute Myeloid Leukemia Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Acute Myeloid Leukemia Market, Supply Chain Analysis
  • Table 4: Global Acute Myeloid Leukemia Market, Major Raw Material Providers
  • Table 5: Global Acute Myeloid Leukemia Market, Major Resource Providers
  • Table 6: Global Acute Myeloid Leukemia Market, Major Manufacturers (Suppliers)
  • Table 7: Global Acute Myeloid Leukemia Market, Major Distributors And Channel Partners
  • Table 8: Global Acute Myeloid Leukemia Market, Key Technologies & Future Trends
  • Table 9: Global Acute Myeloid Leukemia Market, Major Trends
  • Table 10: Global Acute Myeloid Leukemia Market, Major End Users
  • Table 11: Global Acute Myeloid Leukemia Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Acute Myeloid Leukemia Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Acute Myeloid Leukemia Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Acute Myeloid Leukemia Market - TAM, US$ Billion, 2025
  • Table 15: Global Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Acute Myeloid Leukemia Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Acute Myeloid Leukemia Market, Sub-Segmentation Of Stem Cell Transplant, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Acute Myeloid Leukemia Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Acute Myeloid Leukemia Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Acute Myeloid Leukemia Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Acute Myeloid Leukemia Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Acute Myeloid Leukemia Market - Company Scoring Matrix
  • Table 97: Pfizer Inc. Financial Performance
  • Table 98: AbbVie Inc. Financial Performance
  • Table 99: Novartis AG Financial Performance
  • Table 100: Bristol Myers Squibb Company Financial Performance
  • Table 101: F. Hoffmann-La Roche AG Financial Performance
  • Table 102: Global Acute Myeloid Leukemia Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Acute Myeloid Leukemia Market, Competitive Dashboard
  • Table 104: Global Acute Myeloid Leukemia Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Acute Myeloid Leukemia Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Table 106: Global, Acute Myeloid Leukemia Market Size Gain ($ Billion), Segmentation By Treatment Phase, 2025 – 2030
  • Table 107: Global, Acute Myeloid Leukemia Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

    Figure 1: Global Acute Myeloid Leukemia Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Acute Myeloid Leukemia Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Acute Myeloid Leukemia Market, Supply Chain Analysis
  • Figure 4: Global Acute Myeloid Leukemia Market, Major Raw Material Providers
  • Figure 5: Global Acute Myeloid Leukemia Market, Major Resource Providers
  • Figure 6: Global Acute Myeloid Leukemia Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Acute Myeloid Leukemia Market, Major Distributors And Channel Partners
  • Figure 8: Global Acute Myeloid Leukemia Market, Key Technologies & Future Trends
  • Figure 9: Global Acute Myeloid Leukemia Market, Major Trends
  • Figure 10: Global Acute Myeloid Leukemia Market, Major End Users
  • Figure 11: Global Acute Myeloid Leukemia Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Acute Myeloid Leukemia Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Acute Myeloid Leukemia Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Acute Myeloid Leukemia Market - TAM, US$ Billion, 2025
  • Figure 15: Global Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Acute Myeloid Leukemia Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Acute Myeloid Leukemia Market, Sub-Segmentation Of Stem Cell Transplant, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Acute Myeloid Leukemia Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Acute Myeloid Leukemia Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Acute Myeloid Leukemia Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Acute Myeloid Leukemia Market, Segmentation By Treatment Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Acute Myeloid Leukemia Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Acute Myeloid Leukemia Market - Company Scoring Matrix
  • Figure 97: Pfizer Inc. Financial Performance
  • Figure 98: AbbVie Inc. Financial Performance
  • Figure 99: Novartis AG Financial Performance
  • Figure 100: Bristol Myers Squibb Company Financial Performance
  • Figure 101: F. Hoffmann-La Roche AG Financial Performance
  • Figure 102: Global Acute Myeloid Leukemia Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Acute Myeloid Leukemia Market, Competitive Dashboard
  • Figure 104: Global Acute Myeloid Leukemia Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Acute Myeloid Leukemia Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Figure 106: Global, Acute Myeloid Leukemia Market Size Gain ($ Billion), Segmentation By Treatment Phase, 2025 – 2030
  • Figure 107: Global, Acute Myeloid Leukemia Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

Read More About Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Acute Myeloid Leukemia Market Report 2026 - Global Outlook – By Treatment Type (Chemotherapy, Stem Cell Transplant, Targeted Therapy), By Treatment Phase (Induction Therapy, Consolidation Therapy, Maintenance Therapy, Re...

Chronic Myeloid Leukemia Treatment Global Market Report 2025 – By Type (Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant), By Route of Administration (Oral, Parenteral, Other Route of ...

Leqembi Market Report 2026 - Global Outlook – By Formulation (Injectable Formulation (Intravenous), Ready-To-Use Solutions), By Indication (Treatment Of Alzheimer’s Disease, Management Of Mild Cognitive Impairment, Other...

Chronic Myeloid Leukemia Treatment Global Market Report 2025 – By Type (Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant), By Route of Administration (Oral, Parenteral, Other Route of ...

Acute Myeloid Leukemia Market Report 2026 - Global Outlook – By Treatment Type (Chemotherapy, Stem Cell Transplant, Targeted Therapy), By Treatment Phase (Induction Therapy, Consolidation Therapy, Maintenance Therapy, Re...

Myelodysplastic Syndrome Market Report 2026 - Global Outlook – By Type (Myelodysplastic Syndrome With Unilineage Dysplasia, Myelodysplastic Syndrome With Multilineage Dysplasia, Myelodysplastic Syndrome With Ring Siderob...

Leukemia Therapeutics Market Report 2026 - Global Outlook – By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Other Treatments), By Type Of Leukemia (Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Ch...

Chronic Myeloid Leukemia (CML) Treatment Market Report 2026 - Global Outlook – By Type (Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant), By Drug Type (Tyrosine Kinase Inhibitors, Ant...

Frequently Asked Questions

The Acute Myeloid Leukemia market was valued at $3.73 billion in 2025, increased to $3.97 billion in 2026, and is projected to reach $5.25 billion by 2030.

The global Acute Myeloid Leukemia market is expected to grow at a CAGR of 7.3% from 2026 to 2035 to reach $5.25 billion by 2035.

Some Key Players in the Acute Myeloid Leukemia market Include, Pfizer Inc., AbbVie Inc., Novartis AG, Bristol Myers Squibb Company, F. Hoffmann-La Roche AG, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Servier Pharmaceuticals, Amgen Inc., Otsuka Holdings Co. Ltd., Agios Pharmaceuticals Inc., Syndax Pharmaceuticals Inc., MEI Pharma Inc., SELLAS Life Sciences Group, Genmab AS, Aptose Biosciences Inc., Daiichi Sankyo Company Limited, BeiGene Ltd., Jazz Pharmaceuticals plc, Ipsen S.A. .

Major trend in this market includes: Pharmaceutical Companies Enhancing Acute Myeloid Leukemia Treatment Armamentarium With Quizartinib Approval. For further insights on this market. request a sample here

North America was the largest region in the acute myeloid leukemia market in 2025. The regions covered in the acute myeloid leukemia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us